Use of the Water-Soluble Contrast Medium Gastrografin in Treatment of Adhesive Small Bowel Obstruction in Patients with and Without Chronic Radiation Enteropathy: A Single-Center Retrospective Study

27 March 2021: Clinical Research

Lili Gu ^1BCEF , Feng Zhu ^1BDE , Tingbin Xie ^1BCD , Dengyu Feng ^1BEF , Jianfeng Gong ^1BDEG* , Ning Li ^2ABEFG*

DOI: 10.12659/MSM.930046

Med Sci Monit 2021; 27:e930046

Table 5 Multivariable model for features associated with successful non-operative management in CRE-induced SBO and adhesive SBO.

Feature	CRE induced SBO			Adhesive SBO
Feature	OR	95% CI	p	OR	95% CI	p
Age	0.958	0.905–1.015	0.148	1.014	0.962–1.069	0.602
Male sex	2.065	0.618–6.897	0.239	0.534	0.171–1.672	0.534
Radiologic signs
Bowel diameter >25 mm and/or feces sign	1.379	0.823–1.935	0.219	2.412	0.479–4.345	0.391
Beak sign and/or whirl sign and/or agglutinated bowel	2.102	0.469–3.735	0.401	3.315	0.864–12.724	0.081
Mesenteric edema	0.699	0.376–1.022	0.778	1.987	0.764–3.210	0.109
Total dose of radiotherapy	0.911	0.678–1.144	0.041
Successful GG challenge test	4.812	3.343–6.281		3.191	1.447–4.935
Duration of nasogastric tube decompression (>3 days)	2.161	0.059–4.263	0.298	0.781	−0.075–1.637	0.690
Number of previous operations (>2)	0.233	0.131–0.335	0.877	0.560	0.081–1.039	0.431
Region of previous operation (upper abdomen)	1.634	0.628–2.640	0.318	4.918	0.911–8.917	0.091
Type of previous intra-abdominal operation	2.316	0.552–4.080	0.285	0.351	0.088–0.614	0.198
Previous episode of SBO	1.899	0.448–3.350	0.417	0.791	0.368–1.214	0.559
Previous operation for SBO	0.364	0.262–0.466	0.007	0.601	0.136–1.066